Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka 142432, Russia.
Chem Biol Interact. 2010 Sep 6;187(1-3):177-84. doi: 10.1016/j.cbi.2009.12.018. Epub 2009 Dec 23.
This paper reviews previously published data and presents new results to address the hypothesis that fluorinated aminophosphonates (FAPs), (RO)(2)P(O)C(CF(3))(2)NHS(O)(2)C(6)H(5), R=alkyl, inhibit serine esterases by scission of the P-C bond. Kinetics studies demonstrated that FAPs are progressive irreversible inhibitors of acetylcholinesterase (AChE, EC 3.1.1.7.), butyrylcholinesterase (BChE, EC 3.1.1.8.), carboxylesterase (CaE, EC 3.1.1.1.), and neuropathy target esterase (NTE, EC 3.1.1.5.), consistent with P-C bond breakage. Chemical reactivity experiments showed that diMe-FAP and diEt-FAP react with water to yield the corresponding dialkylphosphates and (CF(3))(2)CHNHS(O)(2)C(6)H(5), indicating lability of the P-C bond. X-ray crystallography of diEt-FAP revealed an elongated (and therefore weaker) P-C bond (1.8797 (13)A) compared to P-C bonds in dialkylphosphonates lacking alpha-CF(3) groups (1.805-1.822A). Semi-empirical and non-empirical molecular modeling of diEt-FAP and (EtO)(2)P(O)C(CH(3))(2)NHS(O)(2)C(6)H(5) (diEt-AP), which lacks CF(3) groups, indicated lengthening and destabilization of the P-C bond in diEt-FAP compared to diEt-AP. Active site peptide adducts formed by reacting diEt-FAP with BChE and diBu-FAP with NTE catalytic domain (NEST) were identified using peptide mass mapping with mass spectrometry (MS). Mass shifts (mean+/-SE, average mass) for peaks corresponding to active site peptides with diethylphosphoryl and monoethylphosphoryl adducts on BChE were 136.1+/-0.1 and 108.0+/-0.1Da, respectively. Corresponding mass shifts for dibutylphosphoryl and monobutylphosphoryl adducts on NEST were 191.8+/-0.2 and 135.5+/-0.1Da, respectively. Each of these values was statistically identical to the theoretical mass shift for each dialkylphosphoryl and monoalkylphosphoryl species. The MS results demonstrate that inhibition of BChE and NEST by FAPs yields dialkylphosphoryl and monoalkylphosphoryl adducts, consistent with phosphorylation via P-C bond cleavage and aging by net dealkylation. Taken together, predictions from enzyme kinetics, chemical reactivity, X-ray crystallography, and molecular modeling were confirmed by MS and support the hypothesis that FAPs inhibit serine esterases via scission of the P-C bond.
本文综述了先前发表的数据,并提出了新的结果,以验证氟代氨基膦酸酯(FAPs)(RO)(2)P(O)C(CF(3))(2)NHS(O)(2)C(6)H(5),R=烷基,通过 P-C 键的断裂来抑制丝氨酸酯酶的假说。动力学研究表明,FAPs 是乙酰胆碱酯酶(AChE,EC 3.1.1.7.)、丁酰胆碱酯酶(BChE,EC 3.1.1.8.)、羧酸酯酶(CaE,EC 3.1.1.1.)和神经毒性靶酯酶(NTE,EC 3.1.1.5.)的渐进性不可逆抑制剂,与 P-C 键断裂一致。化学反应性实验表明,二甲基-FAP 和二乙基-FAP 与水反应生成相应的二烷基磷酸盐和(CF(3))(2)CHNHS(O)(2)C(6)H(5),表明 P-C 键不稳定。二乙基-FAP 的 X 射线晶体学揭示了一个伸长的(因此较弱)P-C 键(1.8797(13)A),与缺乏α-CF(3)基团的二烷基磷酸酯的 P-C 键(1.805-1.822A)相比。二乙基-FAP 和(EtO)(2)P(O)C(CH(3))(2)NHS(O)(2)C(6)H(5)(二乙基-AP)的半经验和非经验分子建模表明,与二乙基-AP 相比,二乙基-FAP 的 P-C 键伸长且不稳定。使用质谱(MS)的肽质量图谱鉴定了与 BChE 反应的二乙基-FAP 和与 NTE 催化结构域(NEST)反应的二丁基-FAP 形成的活性部位肽加合物。与 BChE 上具有二乙基膦酰基和单乙基膦酰基加合物的活性部位肽对应的峰的质量位移(平均值+/-SE,平均质量)分别为 136.1+/-0.1 和 108.0+/-0.1Da。与 NEST 上的二丁基膦酰基和单丁基膦酰基加合物对应的质量位移分别为 191.8+/-0.2 和 135.5+/-0.1Da。这些值中的每一个都与每个二烷基膦酰基和单烷基膦酰基物种的理论质量位移统计学上相同。MS 结果表明,FAPs 对 BChE 和 NEST 的抑制导致二烷基膦酰基和单烷基膦酰基加合物的形成,与通过 P-C 键断裂和通过净脱烷基化进行的老化一致。综上所述,来自酶动力学、化学反应性、X 射线晶体学和分子建模的预测得到了 MS 的证实,并支持了 FAPs 通过 P-C 键断裂抑制丝氨酸酯酶的假说。